Currently, laparoscopic adrenalectomy is seen as more than just the preferred method, in fact as a routine procedure, always bearing in mind, however, the developed restraints on its usage. The size of the tumour, recurrent disease, and the existing invasive process all remain factors which determine the indications for operation. The situation is similar in cases of qualifying for sparing (non-radical) operations on adrenal glands. The basic challenge in terms of qualification, choice of technique and the range of operation of adrenal lesions remains: obtaining a reliable preoperative diagnosis, the localisation of lesions including their ectopic location, the evaluation of the imaging phenotype, as well as a proper pre-surgical preparation. Maintaining one third of properly vascularised adrenal mass allows one to avoid a substitutive therapy, with the possible necessity of its application in stressful situations. The first partial adrenalectomy has been conducted on a patient with a bilateral pheochromocytoma, in order to retain the glucocorticoid adrenal functions. The recommendations for its administration remain: hereditary pheochromocytoma of at least 2cm diameter, unilateral adenoma of at least 5cm diameter in Cushing's syndrome without any concomitant lesions in the oposite adrenal gland, and unilateral adenoma in Conn's syndrome. It seems that non-radical resection should always be considered for patients at risk of bilateral adrenalectomy in cases of concomitant lesions in both adrenals. 
Introduction
The main idea of an incomplete (sparing) adrenalectomy is the removal of the lesion recommended for surgery, keeping the unchanged part of the cortex intact. This procedure is designed to retain the corticotropic function of the adrenal, which, in consequence, may allow one to avoid substitute treatment [1, 2] .
This idea, as well as its realisation, is possible, but in practice is hindered by the difficulties in fulfilling conditions of reality, resulting from the canons which a surgical operation performed on adrenals must fulfil. The basic element is to retain the rudimentary oncological principles of the performed operation. This is connected to the need for the evaluation of preoperative risk of malignancy. In these cases, the operation should be conducted completely, i.e. the removal of the entire adrenal along with the lesion without damaging the gland capsule, as well as the adipose tissue of the retroperitoneal area. This is necessary to obtain complete lesion removal, whose nature will eventually be diagnosed by histopathological examination [3] .
A tumour removed in the early stage of its development guarantees a better prognosis. That is why the choice of surgical strategy should be based on the radicality of the first adrenal operation. An assured evaluation of the malignancy of the lesion and its advancement can only be achieved after surgery via
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a pathological examination. Quite often, in cases of pheochromocytoma, even this examination is not able to finally determine whether a malignant process actually occurs [4] . The above general rules concerning surgical techniques required in a treatment of adrenal lesions make it difficult to decide on the question of performing operations that are assumed to be non-radical. On the other hand, contemporary surgery allows the possibility of resecting a tumour in a range necessary for the restoration of the hormone balance. It simultaneously produces conditions allowing for a performance of an adrenal resection that consciously takes into account the appearance of expected hormonal consequences. Additionally, the development of biochemical, genetic, and imaging research allows surgical intervention before any secondary bodily changes (e.g. hormonal preclinical syndromes) have taken place [5] . An additional, though equally important, element influencing the often difficult decision concerning the extent of the tumour resection is the question of substitutive treatment.
Long-term steroid therapy requires constant control, and, more often than not, corrections. It is affected by: stress, infections, performed procedures, diseases, as well as any additional physical or mental stresses. It influences the comfort of life for the patients by means of creating mental restraints on normal activity. It is especially important among young people. It predisposes to early osteoporosis, arterial hypertension, diabetes, and hypoandrogenism in women [2, 6, 7] .
Balancing all the factors that have an influence on the important decisions concerning the time of surgical intervention, as well as its range and the assumption of an appropriate strategy, especially in the cases of bilateral lesions, enhances the range of the therapy of adrenal diseases to include non-radical operations. Additionally, after properly qualifying this kind of an operation, the remaining question is the choice of the method of the operation (classic -open, videoscopic) and the operation access (transperitoneal, retroperitoneal). The development of sparing, non-radical resections as an alternative to the removal of the entire tumour along with the adrenal will, in consequence, allow the patient to gain total physical recovery, simultaneously making a return to mental balance, without any restraints on normal activity, possible [3, 8, 9] .
Selection of patients qualifying for non-radical resection
The recommendations for sparing resection still remain controversial and not clearly defined. The basic recommendation, and simultaneously the idea of sparing resections, is the avoidance of substitutive treatment after surgical operations. In order to obtain such an effect, one must keep as much adrenocortical tissue supplied with blood vessels in place as possible, allowing it to retain its corticotropic function. In order to achieve this, at least one third of the adrenal has to remain intact. The controversy concerns the assessment and the ruling out of malignant processes, as well as the scope of the removal of normal adrenal tissue in order to safely separate it from the tumour, keeping the removal process radical. This is connected to the pre-surgical assessment of the localisation of the lesion, as well as the differentiation of its nature: whether the tumour is single or multiple, whether it is a case of adenoma, or just a hyperplasia [4, 5, 6, 10] .
It would seem that this question concerns only patients in danger of bilateral adrenalectomy, but it is not so. Substitutive treatment is also necessary for patients with unilateral adrenalectomy due to ACTH -independent Cushing's syndrome. The secondary adrenal hypofunction observed after the surgery in a nonoperated adrenal confirms the accurate qualification. This is the result of the suppresion of ACTH secretion due to an excess of cortisol from the operated tumour. This state may remain in place for a long time after the surgery. Despite the fact that a unilateral complete adrenalectomy leaves the patient with a suitable hormonal reserve, the hormonal response in stressful situations might not be sufficient. In these cases, similarly to patients treated by a bilateral complete adrenalectomy receiving a stable, daily dose of steroids, their level in 30% of cases is below the effective dose, especially in stressful situations. Giving too large doses might, on the other hand, cause complications, such as osteoporosis, hypertension, or diabetes after many years. The quality of life of these patients is severely reduced. 30% report feeling constant tiredness and severely constrained activity. 48% of patients consider themselves to be handicapped [11, 12] .
In the cases of unilateral, hormonally inactive tumours/adenoma, aldosteronoma, or pheochromocytoma, the post-surgical adrenal deficiency of the opposite adrenal gland does not appear.
Complete bilateral adrenalectomy necessitates the constant administration of steroids, which facilitates the risk that the symptoms of secondary hypofunction of adrenal cortex will appear. This applies particularly to patients with hereditary pheochromocytoma (multiple endocrine neoplasia syndromes -MEN IIa, Von Hippel Lindau syndrome, neurofibromatosis -1). The lesions appear bilaterally simultaneously, or slightly delayed in the second adrenal. This requires one to consider performing a sparing resection during the first operation, when the lesion is initially unilateral. The chances of a lesion appearing in the second adrenal
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after a unilateral adrenalectomy are estimated to be 14% to 33%. The fact that the successful maintenance of corticotropic functions is dependent on the size of the operated tumour necessitates constant, imaging control study of the remaining, unchanged adrenal. The possibility of an early recognition of the disease, its aetiology, as well as control of the effectiveness and safety of the performed operations, is made available now by routinely performed genetic examination, regular control tests, varied possibilities of imaging technology (USG, CT, MRI) and proper pre-surgical preparation of patients with alpha and beta-blockers.
The value and advantages of such a procedure should be confirmed by screening tests comparing the results to potential deaths and complications associated with Addison syndrome [13] [14] [15] . A benefit in this patient group is the small (2%) possibility of an appearance of malignant pheochromocytoma. The malignant nature of the pheochromocytoma is estimated to be between 2.5% and 26%. An assessment of the malignant nature of the tumour is still very difficult due to a lack of credible criteria. The only assured and credible assessment of the existence of such a process is the discovery of metastatic lesions. A post-surgical pathomorphological examination is also not sufficient to form an unequivocal, credible assessment. It is assumed in the literature that a lack of recurrence of the disease in an operated adrenal for 15 years can rule out the malignancy of pheochromocytoma. Recurrence is estimated to be 6% to 8%. The malignant nature of the lesion is probable in 30% to 40% of tumours located outside the adrenals, and it should also be suspected when hypertension still remains after the surgery. The size of the tumour alone does not represent the level of risk of malignancy, although it is assumed that in young patients with a tumour of a diameter larger than 6 cm, the risk is considered greater. In patients with tumours larger than 10 cm, the risk of metastasis is five times more than in patients with tumours of 4 cm. There is still no clear threshold value that would increase the risk of potential malignancy, such as is present in incidentaloma tumours, where a value of ≥ 4cm has been accepted. If during the routine genetic examination one could state a mutation of the SDHB gene, it should be regarded as a possibility of a malignant process. These patients are more exposed to the risk of a malignant tumour, and the risk itself is estimated to be 30% to 50%. It has also been shown that in patients with malignant pheochromocytoma, the confirmed mutation of the ADHB gene is an independent, negative prognostic factor. The survival period of these patients is significantly shorter. 60% of malignant pheochromocytoma metabolises dopamine, secreting large amounts of methoxytyramine. When its concentration in plasma exceeds 3.0 nml/L, the risk of a cancer is three times as large as in the patients with correct levels of methoxytyramine [6, 13, 15, 16] .
Risk factors of a malignant pheochromocytoma: -hypertension persisting after the surgery, -extra-adrenal location, -young age of the patient, -large size of the tumour, -genetic examination confirming the mutation of the SDHB gene, -elevated concentration of methoxytyranime in plasma.
The size of the tumour has a direct effect on the success of a sparing operation. The most advantageous conditions for the effectiveness of the operation appear in those cases when the tumour is equal to or less than 2 cm in diameter. The cortex layer has not become thinner due to the expanding tumour, while ischaemic lesions are also not present (Fig. 1) [10, 16, 17] .
The assessment of the size of the tumour, its location, and the type of lesions, is very important not only in terms of qualifying the lesions, but also in terms of the performance of the operation and its effectiveness. In our material, in cases of pheochromocytoma, as 
a part of multiple endocrine neoplasia, the lesions in adrenals have always been multiple. Spiral tomography, routinely used in pre-surgical diagnostics, does not differentiate minor lesions, usually only showing the existence of one, large tumour. Only with a pathological examination was it possible to confirm the mid-surgical suspicion of multiple nodules in the adrenal (Fig. 2) [2, 3, 15, 17] . A more precise assessment of lesions is now available using a 3D CT scan. This is recommended for patients qualified for a sparing surgery before the planned operation (Fig. 3) [18, 19] .
It is also for this reason that it is recommended for patients with hereditary tumours associated with minimally symptomatic endocrinopathy to undergo an MIBG scintigraphy as a routine presurgical examination. This plays an important role in the diagnostics of pheochromocytoma and adrenal medulla hypertrophy. It allows one to differentiate between lesions outside the adrenals, paraganglioma or neuroblastoma, as well as primary and metastatic adrenal tumours [15] .
Similarly, regardless of any recommendations concerning a non-radical operation, in order to ensure safety during the complete removal of the lesion causing the disease, a mid-surgery USG examination should be performed.
Recurrences after performing classic (open) sparing operations the literature estimates to be at the level of 33% in MEN syndrome, and 15% in Von Hippel Landau syndrome [16] (Fig. 4) . The first recommendation, which has been very controversial, for a sparing operation of the adrenal cortex is primary aldosteronism -Conn's syndrome [20] [21] [22] .
Elements that, when present, speak in favour of such an operation are:
-an adenoma-type tumour of less than 2 cm; -a cancer, appearing extremely rarely in this kind of condition; -when patients do not require substitutive treatment after the surgery. The main problems, on the other hand, are the factors that serve as causes: adenoma or adrenal hyperplasia. Currently it is estimated that the condition is more often caused by adrenal hyperplasia. Previously it was estimated that in 60% of cases it was adenoma that had been responsible. Patients suffering from an adenoma have more severe hypokalaemia and a higher aldosterone concentration in plasma. Hypokalaemia in Conn's syndrome caused by an adenoma is at a level of < 3.5mmol/L.
The decision to apply a non-radical resection as a means of treating hyperaldosteronism is difficult and associated with a high degree of responsibility on the part the treating team. It stems from several basic elements of obligatory rules: -the basic treatment of a recognised and biochemically confirmed Conn's syndrome is conservative/ drugs sparing potassium defects -aldosterone antagonists, convertase inhibitors, calcium channel blockers; 
-recommendations for a surgical treatment remain as follows:
• non-effectiveness of conservative treatment (uncontrolled low values of potassium in blood); • non-tolerance of conservative treatment;
• confirmation of an adenoma as a cause of the disease. Therefore, for accurate diagnosis of primary aldosteronism, the following localisation tests are recommended: -abdominal ultrasound, -CT of the abdomen, -adrenal scintigraphy, -determination of aldosterone in the adrenal veins, -adrenal venography.
They allow the identification of the causes of primary aldosteronism: -adenoma, -hypertrophy of the adrenal cortex, -idiopathic aldosteronism, -cancer of the adrenal cortex inhibited with glucocorticoids, -ectopic aldosterone secretion [23] . (Fig. 5) The range of resection of the incidentaloma type lesions, due to the lack of specific markers of malignancy, should include excision of the tumour along with the entire adrenal gland and retroperitoneal adipose tissue.
A tumour diameter of ≥ 4 cm, as well as a change in imaging phenotype during the observation, remain joint indications for operation. Rapid growth of the tumour, its irregular shape, or an apparent change in density, should all be a cause for concern and change of operation method. A laparoscopic adrenalectomy via a lateral transperitoneal access remains the preferred surgical treatment.
The only exception from such a procedure is an adrenal endothelial cyst, as well as a non-epithelial pseudocyst, usually being a consequence of bleeding into the adrenal. The non-radical resection of the gland encompasses then only the removal of the cyst (Fig. 6 ) [2, 3, 24] .
In USG, the lesion is anechoic, with an enhancement of the echo behind the rear wall, characteristic for a fluid. In a CT scan image without contrast media, the density of the cyst is low, with values typical of a fluid. Differentiating between this and an adenoma is in these cases difficult. After administering a contrast, the image of the cyst is unequivocal, without any contrast enhancement patterns.
An MRI allows one to acquire an unequivocal image of the cyst. It shows a strong signal on the T2-weighted images, and a reduced one on T1-weighted images, which is typical of a fluid. There is no contrast-based enhancement of the lesion [24] . 

Indications for non-radical, sparing resections
Despite the numerous controversies presented above, the current indications considered for adrenal gland sparing are: -bilateral hereditary pheochromocytoma, • endocrine syndrome MEN I and II a) MEN -endocrine tumours of the pituitary, parathyroid, pancreas, pheochromocytoma; b) MEN IIa -pheochromocytoma, medullary carcinoma of the thyroid, parathyroid adenoma, c) MEN IIb -pheochromocytoma, medullary thyroid carcinoma, marfanoid body habitus, mucosal neuromas, intestinal ganglioneuromas;
• von Hippel-Lindau syndrome -pheochromocytoma, clear cell renal carcinomas, hemangioblastoma of parenchymal organs and nervous system; • neurofibromatosis type 1 -pheochromocytoma, not less than two neurofibromas (any type); • hereditary pheochromocytoma-paraganglioma syndrome (PGL); • unilateral pheochromocytoma in documented genetic cases; -primary aldosteronism due to unilateral adrenal adenoma with the oposite normal adrenal gland; -unilateral adrenal adenoma in Cushing's syndrome; -pseudocyst or adrenal endothelial cyst [9, 10, 16-18, 20, 22, 25-27] . 
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Surgical aspects of non-radical operations
Surgery is an essential element of the treatment of adrenal gland disorders. Classical open operations are performed and operations using minimally invasive methods: videoscopic, laparoscopic [8] . Currently, laparoscopy is a reference method. This also applies to sparing adrenal surgery.
Conditions for the preservation of adrenocorticotropic function of the operated adrenal gland and complete elimination of the lesion: -leaving as much normal tissue as is required to preserve the function of the cortex -a minimum of one third of the gland; -excision with a margin of 3-5 mm of normal, healthy tissue; -the size of the qualified lesions:
• pheochromocytoma ≤ 2 cm in diameter of tumour (Fig. 7) ,
Figure 6. Evaluation of imaging phenotype of adrenal lesions
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• Cushing's syndrome ≤ 5 cm of unilateral tumour size • Conn's syndrome -the adenoma of one adrenal with undoubtedly healthy second adrenal gland (Fig. 8 
), -efficacy is comparable between videoscopic and
classical open methods, -securing or not the central adrenal vein does not affect the final result, -preservation of blood supply to the remaining part of the gland plays an important role [9, 17, 18, 20, 25, 26, 28] . Despite the comparable effectiveness of both methods (classical -open, videoscopic), the laparoscopic operations are more likely to create opportunities to meet these conditions. Sparing laparoscopic adrenalectomy: -less traumatic than the classical method, with as a consequence smaller release of catecholamines, -the ability to maintain and visualise small vessels, -easier dissection during resection, -control of vein and its ligation, -obtaining extensive operating field in the retroperitoneal space. The controversy associated with securing the central adrenal vein during incomplete resections also remains within the realm of discussion. Nonetheless, based on multicentre experiences, the results obtained have not differed much between cases when the vein was tied/ /clipped, and when it was not. However, in a situation when the lesion is located directly in the adrenal vein flow, clipping it is necessary. The basic condition of retaining the adrenocorticotropic function is sparing of minor vessels supplying the remaining fragment of the adrenal. This is why the localisation of the lesion in pre-surgical examinations, as well as the possibility of performing a mid-surgical USG examination, mentioned by many authors, is so important. It would seem that a routine 3D CT scan performed before the patient's qualification for a sparing resection allows one to increase the safety and effectiveness of such a surgery.
The resection of the lesion should be performed with a 3-5mm margin of unchanged cortex. Bleeding control in the location of the cut can be achieved by the application of stitches, or by using tools applying varying methods of homeostasis (electrocoagulation, a harmonic knife, a LigaSure, or bicision) [3, 5, 9, 17, 18, 26, 28] (Fig. 9) .
Conclusion
Surgical treatment is the basic form of adrenal lesion treatment. The introduction of semi-invasive operations has caused a change in surgical strategy, simultaneously 
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expanding the scope of the operation. The technologies used for adrenal imaging (CT scan, MRI, PET/CTscans) allow one to detect smaller and smaller adrenal lesions, as well as enabling one to differentiate between benign and malignant lesions. They make it possible to assess the size of the infiltration and the localisation of the lesions in relation to the surrounding structures. This has brought about a situation in which mid-surgical assessment is used more rarely to determine the range of the gland resection. Simultaneously, it makes a resection of the gland in a scope necessary for the restoration of hormone balance possible, also allowing for an intervention before any secondary systemic changes appear. This is why the consideration of the retention of the cortical function of the adrenal becomes mandatory for patients in whom the disease qualified for surgery is eliminated, simultaneously allowing them to avoid the substitutive treatment. Multicentre studies confirm the possibility of performing a non-radical surgery, as well as its safety and effectiveness; they also show low morbidity of not only the unilateral, but also bilateral, especially partial adrenalectomy. The introduction of minimally invasive methods into the surgical techniques used in the treatment of adrenal lesions has created new possibilities positively influencing the development of these types of operations. The recommendations and rules concerning the usage of these methods, however, are not yet fully developed.
Polish version
Wstęp
Istotą niekompletnej (oszczędzającej) adrenalektomii jest usunięcie zmiany odpowiadającej za wskazania do operacji z pozostawieniem części niezmienionej kory. Postępowanie to ma służyć zachowaniu funkcji kortykotropowej nadnercza, co może w konsekwencji pozwolić na uniknięcie leczenia substytucyjnego, zastępczego [1, 2] .
Zarówno idea, jak i jej realizacja jest możliwa, lecz w praktyce napotyka trudne do spełnienia realia wynikające z kanonów jakie musi spełniać wykonywana operacja nadnerczy. Podstawowym elementem jest zachowanie zasad onkologicznych przeprowadzanej operacji. Wiąże się to z koniecznością przedoperacyjnego określenia zagrożenia procesem rozrostowym. Operacja w tych przypadkach powinna być wykonana doszczętnie, to znaczy wycięcie całego nadnercza wraz ze zmianą bez uszkodzenia torebki gruczołu oraz tkanką tłuszczową przestrzeni zaotrzewnowej. Jest to warunek uzyskania doszczętności wycięcia zmiany, o której charakterze ostateczną odpowiedź da dopiero badanie histopatologiczne [3] .
SZKOLENIE PODYPLOMOWE
usunięcia całkowicie zmiany wywołującej chorobę, powinna być wykonana śródoperacyjna ocena USG. Nawroty po wykonanych klasycznych -otwartych operacjach oszczędzających w literaturze oceniane są w zespole MEN na 33%, a von Hippla-Lindaua na 15% (ryc. 4) [16] .
Pierwszym wskazaniem, a jednocześnie do chwili obecnej bardzo kontrowersyjnym, do wykonania operacji oszczędzających korę nadnerczy jest pierwotny hiperaldosteronizm -zespół Conna [20] [21] [22] .
Niezaprzeczalnymi walorami przemawiającymi za wykonywaniem tego typu operacji jest: -guz o charakterze gruczolaka małej średnicy około 2 cm, -wyjątkowo rzadko występujący rak w tym schorzeniu, -chorzy po operacji nie wymagają stosowania leczenia substytucyjnego. Podstawowy problem stanowi zaś zróżnicowanie przyczyny go wywołującej: gruczolak czy przerost kory nadnerczy. Aktualnie ocenia się, że częściej schorzenie spowodowane jest przerostem kory nadnercza.
Uprzednio oceniano, że w 60% odpowiedzialny był gruczolak. Chorzy z gruczolakiem mają bardziej nasiloną hipokaliemię oraz większe stężenie aldosteronu w osoczu. Hipokaliemia w zespole Conna uwarunkowana gruczolakiem jest < 3.5 mmol/l.
Decyzja o wyborze nieradykalnej resekcji jako metodzie leczenia pierwotnego hiperaldosteronizmu jest trudna i związana z dużą odpowiedzialnością zespołu leczącego. Wynika to z kilku podstawowych elementów związanych z obowiązującymi zasadami: 
-podstawowym leczeniem rozpoznanego i potwierdzonego biochemicznie zespołu Conna jest leczenie zachowawcze (leki oszczędzające ubytki potasu -antagoniści aldosteronu, inhibitory konwertazy, antagoniści wapnia), -wskazaniem do leczenia operacyjnego pozostaje:
• nieskuteczność leczenia zachowawczego (niekontrolowane niskie wartości potasu w surowicy krwi), • nietolerancja leczenia zachowawczego, • potwierdzenie istnienia gruczolaka jako przyczyny wywołującej chorobę. Dlatego też dla dokładnej oceny przyczyn pierwotnego hiperaldosteronizmu zalecane są badania lokalizacyjne: -USG jamy brzusznej, -CT jamy brzusznej, -scyntygrafia nadnerczy, -oznaczanie aldosteronu w żyłach nadnerczowych, -flebografia nadnerczowa.
Pozwalają one na zróżnicowanie przyczyn go wywołujących: -gruczolak, -przerost kory nadnercza, -idiopatyczny hiperaldosteronizm, -rak kory nadnerczy hamowany glikokortykoidami, -ektopowe wydzielanie aldosteronu [23] (ryc. 5).
W zmianach typu incydentaloma zakres resekcji, ze względu na brak swoistych markerów złośliwości, powinien obejmować wycięcie guza wraz z całym nadnerczem oraz tkanką tłuszczową przestrzeni zaotrzewnowej.
Wskazaniem do operacji pozostaje średnica guza ≥ 4 cm oraz zmiana fenotypu obrazowego w czasie obserwacji. Raptowny wzrost guza, nieregularny jego kształt lub pojawienie się zmiany densyjności powinien budzić niepokój i powodować kwalifikację zmiany do operacji. Referencyjnym leczeniem operacyjnym jest laparoskopowa adrenalektomia z dostępu bocznego przezotrzewnowego.
Jedynym wyjątkiem od takiego postępowania jest torbiel nadnercza endotelialna oraz nieposiadająca nabłonka torbiel rzekoma będąca zwykle następstwem krwawienia do nadnercza. Nieradykalna resekcja gruczołu obejmuje wówczas tylko usunięcie torbieli (ryc. 6) [2, 3, 24] .
W USG zmiana jest bezechowa z typowym dla płynu wzmocnieniem echa za tylną ścianą. W obrazie tomografii komputerowej (CT) bez wzmocnienia kontrastowego, gęstość torbieli jest niska o wartościach typowych dla płynu. Różnicowanie w tych przypadkach z gruczolakiem jest trudne. Po podaniu kontrastu obraz torbieli jest jednoznaczny, gdyż nie ulega wzmocnieniu.
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PODYPLOMOWE Rezonans magnetyczny (MRI) pozwala na uzyskanie jednoznacznego obrazu torbieli. Wykazuje ona typowy dla płynu silny sygnał w obrazach T2-zależnych oraz obniżony w obrazach T1-zależnych. Nie stwierdza się kontrastowego wzmocnienia zmiany [24] .
Wskazania do nieradykalnych oszczędzających resekcji
Mimo licznych kontrowersji, zaprezentowanych powyżej, obecnie za wskazania do rozważenia wykonania oszczę-dzającej resekcji gruczołu nadnerczowego uważa się: -obustronne pheochromocytoma uwarunkowane dziedzicznie:
• zespół gruczolakowatości wewnątrzwydzielni-czej MEN I i II:
a) MEN I -guzy endokrynne przysadki, przytarczyc, trzustki, pheochromocytoma; b) MEN IIa -pheochromocytoma, rak rdzeniasty tarczycy, gruczolak przytarczyc; c) MEN IIb -pheochromocytoma, rak rdzeniasty tarczycy, marfanoidalne cechy budowy, nerwiaki błon śluzowych, hiperganglioza jelit; • choroba von Hippla-Lindaua -guz chromochłonny, rak jasnokomórkowy nerki, hemangioblastoma narządów miąższowych i układu nerwowego, • nerwiakowłókniakowatość typu 1 -guz chromochłonny, nie mniej niż 2 nerwiako-włókniaki dowolnego typu; • zespół guza chromochłonnego i przyzwojaków (PGL);
